Cornelis L. Verweij - Concepedia

Author

Cornelis L. Verweij

Amsterdam UMC Location Vrije Universiteit Amsterdam

Also Known As

Cornelis L Verweij, Cornelis L. Verweij, Cornelis Verweij, Cornelis L. Verweij

Publications

7.5K

Citations

H-Index

Concepts

All Affiliations

Amsterdam UMC Location Vrije Universiteit Amsterdam Leiden University Medical Center University of Amsterdam Amsterdam UMC Location University of Amsterdam Reade

About

Cornelis L. Verweij is an author at Amsterdam UMC Location Vrije Universiteit Amsterdam specializing in medicine, immunology, and autoimmune disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	14	3.7K
2	Allergy	3	3	244
3	Engineering	1	1	16
4	Natural Sciences	1	1	83
5	Public Health	1	1	221

Cornelis L. Verweij

Publications

7.3K

Citations

H-Index

Page 1

	Year	Citations
The β-Catenin/TCF-4 Complex Imposes a Crypt Progenitor Phenotype on Colorectal Cancer Cells Marc van de Wetering, Elena Sancho, Cornelis L. Verweij, Cell Crypt Progenitor PhenotypeTumor BiologyMedicineCancer Cell BiologyColorectal Cancer	2002	2K
Genetic influence on cytokine production and fatal meningococcal disease Rudi GJ Westendorp, Jan A. M. Langermans, T. Huizinga, The Lancet CytokineDisease SusceptibilityPathogenesisImmunologyGenetic Influence	1997	807
Cyclosporin A Specifically Inhibits Function of Nuclear Proteins Involved in T Cell Activation Elizabeth Ann Emmel, Cornelis L. Verweij, David B. Durand, Science	1989	677
Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis Floris A. van Gaalen, Jill van Aken, T. Huizinga, Arthritis & Rheumatism	2004	394
Rheumatoid arthritis is a heterogeneous disease: Evidence for differences in the activation of the STAT‐1 pathway between rheumatoid tissues Tineke C. T. M. van der Pouw Kraan, F. van Gaalen, Pia V. Kasperkovitz, Arthritis & Rheumatism	2003	258
TNF-α promoter polymorphisms, production and susceptibility to multiple sclerosis in different groups of patients T. Huizinga, Rudi G. J. Westendorp, Eduard L. E. M. Bollen, Journal of Neuroimmunology Disease SusceptibilityAutoimmune DiseaseNeurological DisorderMedicineImmunology	1997	221
The interferon type I signature towards prediction of non-response to rituximab in rheumatoid arthritis patients Hennie G. Raterman, Saskia Vosslamber, Sander de Ridder, Arthritis Research & Therapy	2012	184
Construction of cDNA coding for human von Willebrand factor using antibody probes for colony-screening and mapping of the chromosomal gene Cornelis L. Verweij, Carlie J.M. de Vries, Ben Distel, Nucleic Acids Research GeneticsImmunologyGene CharacterizationMolecular GeneticsDisease Gene Identification	1985	161
Inflammation and ectopic lymphoid structures in rheumatoid arthritis synovial tissues dissected by genomics technology: Identification of the interleukin‐7 signaling pathway in tissues with lymphoid neogenesis Trieneke C. G. Timmer, Belinda Baltus, Mark F. R. Vondenhoff, Arthritis & Rheumatism	2007	160
The type I IFN signature as a biomarker of preclinical rheumatoid arthritis Joyce Lübbers, Mikael Brink, Lotte A van de Stadt, Annals of the Rheumatic Diseases	2013	157

Page 1